Headlines | June 5th

Markets

Market performance of publicly-listed psychedelic companies for the week of June 1st - 5th

Deals/Updates

MindMed ($MMED | $MMEDF) launched Project Lucy, focused on LSD experiental therapy for anxiety disorders (Press Release). The company also expanded their Phase 2 clinical trial of microdosing LSD for adult ADHD. Press Release

‍NeonMind Biosciences, a wholly-owned subsidiary of The Yield Growth Corp ($BOSS | $BOSQF | $YG3), filed for a U.S. provisional patent to use psychedelic-assisted psychotherapy for weight loss. Press Release

‍Pure Extracts Corp. (Private) is raising C$5,000,000 in their IPO round at a pre-money valuation of $16MM. Feature

‍Numinus ($NUMI) announced the appointment of Dr. Devon Christie to the position of Medical Director. Press Release

‍New Wave Holdings Corp ($SPOR | $TRMNF | $0XM2) announced that they will provide funding support for the Delos Psyche Research Group to determine the effects of microdosing LSD on patients suffering from depression, anxiety and stress. Press Release

‍View All News

‍

Media

MindMed ($MMED | $MMEDF) was featured in Vice and Business Insider

‍Champignon Brands ($SHRM | $SHRMF | $496) released a video showcasing the recently acquired Wellness Clinic of Orange County.

‍Psychedelic Finance interviewed Adam Halberstadt, Ph.D., Associate Professor of Psychiatry at University of California San Diego. Interview Link

‍Founder Spotlight Video: Payton Nyquvest, CEO of Numinus ($NUMI)